Federico Martinon-Torres
@fedemartinon.bsky.social
Pediatrician and Clinical Researcher. Hospital Clínico Universitario de Santiago (Spain). Genetics, Vaccines, Infections and Pediatrics Research Group (GENVIP-www.genvip.eu)
Almost here!!
Are you going to miss it? Save the date! See you in Santiago de Compostela 20-21 november 2025!! Www.tipicosantiago.com
November 2, 2025 at 9:04 PM
Almost here!!
Reposted by Federico Martinon-Torres
Are you going to miss it? Save the date! See you in Santiago de Compostela 20-21 november 2025!! Www.tipicosantiago.com
April 7, 2025 at 7:49 PM
Are you going to miss it? Save the date! See you in Santiago de Compostela 20-21 november 2025!! Www.tipicosantiago.com
Open letter in support of WHO - The Lancet www.thelancet.com/journals/lan...
Open letter in support of WHO
The abrupt cessation of global health funding has placed millions of lives at risk.1
This sudden funding freeze violates basic bioethical principles and values, including
human rights, universality, a...
www.thelancet.com
June 18, 2025 at 6:54 PM
Open letter in support of WHO - The Lancet www.thelancet.com/journals/lan...
RSV prevention: public health lessons from the southern hemisphere - The Lancet Infectious Diseases www.thelancet.com/journals/lan... @thelancetinfdis.bsky.social
RSV prevention: public health lessons from the southern hemisphere
The NIRSE-CL study by Juan Pablo Torres and colleagues,1 published in The Lancet Infectious
Diseases, is a landmark analysis of the first nationwide implementation of nirsevimab
in the southern hemisp...
www.thelancet.com
June 11, 2025 at 6:44 PM
RSV prevention: public health lessons from the southern hemisphere - The Lancet Infectious Diseases www.thelancet.com/journals/lan... @thelancetinfdis.bsky.social
Vaccine-preventable respiratory diseases affect all ages, yet barriers to access and policy gaps in implementation limit prevention efforts. It’s time to prioritise and enhance access!
#ESPID #RSV #PneumococcalDisease #PublicHealth #Vaccination #ESPID25
#ESPID #RSV #PneumococcalDisease #PublicHealth #Vaccination #ESPID25
May 25, 2025 at 6:01 PM
Vaccine-preventable respiratory diseases affect all ages, yet barriers to access and policy gaps in implementation limit prevention efforts. It’s time to prioritise and enhance access!
#ESPID #RSV #PneumococcalDisease #PublicHealth #Vaccination #ESPID25
#ESPID #RSV #PneumococcalDisease #PublicHealth #Vaccination #ESPID25
Are you going to miss it? Save the date! See you in Santiago de Compostela 20-21 november 2025!! Www.tipicosantiago.com
April 7, 2025 at 7:49 PM
Are you going to miss it? Save the date! See you in Santiago de Compostela 20-21 november 2025!! Www.tipicosantiago.com
Reposted by Federico Martinon-Torres
El éxito clínico de las vacunas contra la #covid hubiera sido imposible en España si no se hubiera aligerado la burocracia, apunta Federico Martinón en el foro de @efe.com efecomunica.efe.com/evento/efe-f...
EFE Fórum Salud “COVID, CINCO AÑOS DESPUÉS: ¿EN QUÉ MOMENTO ESTAMOS?
EFE Fórum Salud “COVID, CINCO AÑOS DESPUÉS: ¿EN QUÉ MOMENTO ESTAMOS?” analizamos junto a autoridades públicas y destacadas.
efecomunica.efe.com
March 26, 2025 at 12:27 PM
El éxito clínico de las vacunas contra la #covid hubiera sido imposible en España si no se hubiera aligerado la burocracia, apunta Federico Martinón en el foro de @efe.com efecomunica.efe.com/evento/efe-f...
Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions pubmed.ncbi.nlm.nih.gov/40024259/
Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study - PubMed
None.
pubmed.ncbi.nlm.nih.gov
March 6, 2025 at 9:14 PM
Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions pubmed.ncbi.nlm.nih.gov/40024259/
Novedades en inmunización pediátrica www.pediatriaintegral.es/wp-content/u...
www.pediatriaintegral.es
March 6, 2025 at 9:13 PM
Novedades en inmunización pediátrica www.pediatriaintegral.es/wp-content/u...
How to improve pertussis vaccination in pregnancy: a European expert review pubmed.ncbi.nlm.nih.gov/40042539/
How to improve pertussis vaccination in pregnancy: a European expert review - PubMed
Ongoing surveillance and registers documenting vaccine uptake in pregnant women are important to monitor changes in pertussis epidemiology and estimated effectiveness of maternal pertussis vaccination...
pubmed.ncbi.nlm.nih.gov
March 6, 2025 at 9:12 PM
How to improve pertussis vaccination in pregnancy: a European expert review pubmed.ncbi.nlm.nih.gov/40042539/
Reposted by Federico Martinon-Torres
Latest paper from the DIAMONDS consortium led by Antonio Salas and Federico Martinon-Torres at SERGAS, Spain
www.nature.com/articles/s41...
www.nature.com/articles/s41...
A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment - Nature Communications
Using blood microarray data from 107 children with pneumonia, the authors here identify eight transcriptomic signatures that distinguish Mycoplasma pneumoniae pneumonia from other viral and bacterial ...
www.nature.com
January 15, 2025 at 4:00 PM
Latest paper from the DIAMONDS consortium led by Antonio Salas and Federico Martinon-Torres at SERGAS, Spain
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Federico Martinon-Torres
🤧Dous novos estudos da USC poderían transformar a forma en que se diagnostican e tratan as infeccións pulmonares infantís
As investigacións lideradas polos profesores Antonio Salas e Federico Martinón mellorarían a precisión, personalización e eficacia dos tratamentos
🗞️ www.usc.gal/gl/xornal/no...
As investigacións lideradas polos profesores Antonio Salas e Federico Martinón mellorarían a precisión, personalización e eficacia dos tratamentos
🗞️ www.usc.gal/gl/xornal/no...
February 24, 2025 at 11:02 AM
🤧Dous novos estudos da USC poderían transformar a forma en que se diagnostican e tratan as infeccións pulmonares infantís
As investigacións lideradas polos profesores Antonio Salas e Federico Martinón mellorarían a precisión, personalización e eficacia dos tratamentos
🗞️ www.usc.gal/gl/xornal/no...
As investigacións lideradas polos profesores Antonio Salas e Federico Martinón mellorarían a precisión, personalización e eficacia dos tratamentos
🗞️ www.usc.gal/gl/xornal/no...
Reposted by Federico Martinon-Torres
El #TIPiCO ya está de vuelta: 20 y 21 de noviembre de 2025, donde siempre y con los de siempre: Ron Dagan, Shamez Ladhani, Andrew Pollard, Ab Osterhaus, Pierre Van Damme, Patrick Meyer Sauteur, Louis Bont …y más! Plazas limitadas, por orden inscripción!
February 17, 2025 at 7:14 AM
El #TIPiCO ya está de vuelta: 20 y 21 de noviembre de 2025, donde siempre y con los de siempre: Ron Dagan, Shamez Ladhani, Andrew Pollard, Ab Osterhaus, Pierre Van Damme, Patrick Meyer Sauteur, Louis Bont …y más! Plazas limitadas, por orden inscripción!
El #TIPiCO ya está de vuelta: 20 y 21 de noviembre de 2025, donde siempre y con los de siempre: Ron Dagan, Shamez Ladhani, Andrew Pollard, Ab Osterhaus, Pierre Van Damme, Patrick Meyer Sauteur, Louis Bont …y más! Plazas limitadas, por orden inscripción!
February 17, 2025 at 7:14 AM
El #TIPiCO ya está de vuelta: 20 y 21 de noviembre de 2025, donde siempre y con los de siempre: Ron Dagan, Shamez Ladhani, Andrew Pollard, Ab Osterhaus, Pierre Van Damme, Patrick Meyer Sauteur, Louis Bont …y más! Plazas limitadas, por orden inscripción!
El #TiPICO ya está calentando motores. 20 y 21 de noviembre de 2025, en Santiago de Compostela …la fórmula de siempre: los mejores ponentes y los temas de máximo interés: Osterhaus, Dagan, Bont…Bloquea tu calendario. Más info pronto en tipicosantiago.com. Reserva tu plaza!
TiPICO
TiPICO es el Taller interactivo Infectológico que tiene lugar en Santiago de Compostela / TiPICO is the interactive Infectious Disease Workshop that takes place in Santiago de Compostela.
tipicosantiago.com
February 5, 2025 at 11:13 AM
El #TiPICO ya está calentando motores. 20 y 21 de noviembre de 2025, en Santiago de Compostela …la fórmula de siempre: los mejores ponentes y los temas de máximo interés: Osterhaus, Dagan, Bont…Bloquea tu calendario. Más info pronto en tipicosantiago.com. Reserva tu plaza!
Critical assessment of uncertainty in economic evaluations on influenza vaccines for the elderly population in Spain bmcinfectdis.biomedcentral.com/articles/10....
Critical assessment of uncertainty in economic evaluations on influenza vaccines for the elderly population in Spain - BMC Infectious Diseases
Background Influenza is a seasonal infection with a huge impact on morbidity and mortality in older adults, for whom vaccination is recommended. New influenza vaccines for this population have been in...
bmcinfectdis.biomedcentral.com
February 2, 2025 at 9:15 AM
Critical assessment of uncertainty in economic evaluations on influenza vaccines for the elderly population in Spain bmcinfectdis.biomedcentral.com/articles/10....
A Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix® Vaccine When Given to Healthy Infants at 3 and 12 Months of Age
pubmed.ncbi.nlm.nih.gov/39883399/
pubmed.ncbi.nlm.nih.gov/39883399/
A Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix® Vaccine When Given to Healthy Infants at 3 and 12 Months of Age - PubMed
ClinicalTrials.gov, NCT04819113.
pubmed.ncbi.nlm.nih.gov
January 30, 2025 at 6:25 PM
A Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix® Vaccine When Given to Healthy Infants at 3 and 12 Months of Age
pubmed.ncbi.nlm.nih.gov/39883399/
pubmed.ncbi.nlm.nih.gov/39883399/
Hoy 29-enero-25, a las 1930 CET, en el marco del congreso virtual, tendrá lugar la conferencia "El poder de los datos en la investigación en vacunas", por si es de vuestro interés. Más informacion 👇
Ya ha comenzado el Congreso Virtual Vacunas 2025 | Tomando acción por la vacunación. Siempre se aprende escuchando a Jose Antonio Navarro.
profesionales.msd.es/webinars/con...
profesionales.msd.es/webinars/con...
January 29, 2025 at 1:59 PM
Hoy 29-enero-25, a las 1930 CET, en el marco del congreso virtual, tendrá lugar la conferencia "El poder de los datos en la investigación en vacunas", por si es de vuestro interés. Más informacion 👇
Reposted by Federico Martinon-Torres
Ya ha comenzado el Congreso Virtual Vacunas 2025 | Tomando acción por la vacunación. Siempre se aprende escuchando a Jose Antonio Navarro.
profesionales.msd.es/webinars/con...
profesionales.msd.es/webinars/con...
January 27, 2025 at 5:18 PM
Ya ha comenzado el Congreso Virtual Vacunas 2025 | Tomando acción por la vacunación. Siempre se aprende escuchando a Jose Antonio Navarro.
profesionales.msd.es/webinars/con...
profesionales.msd.es/webinars/con...
Reposted by Federico Martinon-Torres
🚨 Breaking: Full 2023-24 results from the NIRSE-GAL study in Galicia, Spain, confirm effectiveness of universal nirsevimab prophylaxis in preventing RSV-related hospitalizations in infants. 📖 Published at Lancet Infectious Diseases www.thelancet.com/callback?red...
Lancet
www.thelancet.com
January 18, 2025 at 11:37 PM
🚨 Breaking: Full 2023-24 results from the NIRSE-GAL study in Galicia, Spain, confirm effectiveness of universal nirsevimab prophylaxis in preventing RSV-related hospitalizations in infants. 📖 Published at Lancet Infectious Diseases www.thelancet.com/callback?red...
Reposted by Federico Martinon-Torres
Our last publicación in @natureportfolio.bsky.social: A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment PubMed.ncbi.nlm.nih.gov/39809748/
A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment - PubMed
Mycoplasma pneumoniae causes atypical pneumonia in children and young adults. Its lack of a cell wall makes it resistant to beta-lactams, which are the first-line treatment for typical pneumonia. Curr...
PubMed.ncbi.nlm.nih.gov
January 18, 2025 at 11:45 PM
Our last publicación in @natureportfolio.bsky.social: A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment PubMed.ncbi.nlm.nih.gov/39809748/
Reposted by Federico Martinon-Torres
Charla divulgativa:
"La magia de las vacunas"
30 enero de 2025, 1830 horas
Inscripcion: survey.zohopublic.com/zs/9iClxN
Lugar: Edificio Grupo Quatrium
C/ Amio 130, 15707, Santiago de Compostela
Fecha: Jueves, 30 enero
Hora: 18.30h
Os esperamos
"La magia de las vacunas"
30 enero de 2025, 1830 horas
Inscripcion: survey.zohopublic.com/zs/9iClxN
Lugar: Edificio Grupo Quatrium
C/ Amio 130, 15707, Santiago de Compostela
Fecha: Jueves, 30 enero
Hora: 18.30h
Os esperamos
January 21, 2025 at 9:11 AM
Charla divulgativa:
"La magia de las vacunas"
30 enero de 2025, 1830 horas
Inscripcion: survey.zohopublic.com/zs/9iClxN
Lugar: Edificio Grupo Quatrium
C/ Amio 130, 15707, Santiago de Compostela
Fecha: Jueves, 30 enero
Hora: 18.30h
Os esperamos
"La magia de las vacunas"
30 enero de 2025, 1830 horas
Inscripcion: survey.zohopublic.com/zs/9iClxN
Lugar: Edificio Grupo Quatrium
C/ Amio 130, 15707, Santiago de Compostela
Fecha: Jueves, 30 enero
Hora: 18.30h
Os esperamos
Charla divulgativa:
"La magia de las vacunas"
30 enero de 2025, 1830 horas
Inscripcion: survey.zohopublic.com/zs/9iClxN
Lugar: Edificio Grupo Quatrium
C/ Amio 130, 15707, Santiago de Compostela
Fecha: Jueves, 30 enero
Hora: 18.30h
Os esperamos
"La magia de las vacunas"
30 enero de 2025, 1830 horas
Inscripcion: survey.zohopublic.com/zs/9iClxN
Lugar: Edificio Grupo Quatrium
C/ Amio 130, 15707, Santiago de Compostela
Fecha: Jueves, 30 enero
Hora: 18.30h
Os esperamos
January 21, 2025 at 9:11 AM
Charla divulgativa:
"La magia de las vacunas"
30 enero de 2025, 1830 horas
Inscripcion: survey.zohopublic.com/zs/9iClxN
Lugar: Edificio Grupo Quatrium
C/ Amio 130, 15707, Santiago de Compostela
Fecha: Jueves, 30 enero
Hora: 18.30h
Os esperamos
"La magia de las vacunas"
30 enero de 2025, 1830 horas
Inscripcion: survey.zohopublic.com/zs/9iClxN
Lugar: Edificio Grupo Quatrium
C/ Amio 130, 15707, Santiago de Compostela
Fecha: Jueves, 30 enero
Hora: 18.30h
Os esperamos
Our last publicación in @natureportfolio.bsky.social: A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment PubMed.ncbi.nlm.nih.gov/39809748/
A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment - PubMed
Mycoplasma pneumoniae causes atypical pneumonia in children and young adults. Its lack of a cell wall makes it resistant to beta-lactams, which are the first-line treatment for typical pneumonia. Curr...
PubMed.ncbi.nlm.nih.gov
January 18, 2025 at 11:45 PM
Our last publicación in @natureportfolio.bsky.social: A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment PubMed.ncbi.nlm.nih.gov/39809748/
🚨 Breaking: Full 2023-24 results from the NIRSE-GAL study in Galicia, Spain, confirm effectiveness of universal nirsevimab prophylaxis in preventing RSV-related hospitalizations in infants. 📖 Published at Lancet Infectious Diseases www.thelancet.com/callback?red...
Lancet
www.thelancet.com
January 18, 2025 at 11:37 PM
🚨 Breaking: Full 2023-24 results from the NIRSE-GAL study in Galicia, Spain, confirm effectiveness of universal nirsevimab prophylaxis in preventing RSV-related hospitalizations in infants. 📖 Published at Lancet Infectious Diseases www.thelancet.com/callback?red...